Loading clinical trials...
Loading clinical trials...
The aim of present study is to evaluate the efficacy and safety of Extended-Release Carvedilol Sulfate versus in Patients With Mild or Moderate Primary Hypertension
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
NCT07481981 · Pulmonary Arterial Hypertension
NCT07606859 · Hypertension Arterial, 65 Years Older
NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more
NCT07578090 · Hypertension, Cardiovascular Disease, and more
NCT07280390 · Cirrhosis, Microplastics, and more
Gansu Provincial Hospital
Lanzhou, Gansu
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei
The Second Xiangya Hospital of Central South University
Changsha, Hunan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions